SCHEMBL4823641

SCHEMBL4823641

CCCCCCCCCCCCCCN[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 2/20 0.60
GPR84 Q9NQS5 7/20 0.48
PPARG P37231 7/20 0.48
PPARD Q03181 7/20 0.48
PPARA Q07869 7/20 0.48
HDAC11 Q96DB2 5/20 0.48
TSHR P16473 4/20 0.48
PTPN1 P18031 3/20 0.48
ALDH1A1 P00352 2/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
FABP4 P15090 2/20 0.48
FFAR4 Q5NUL3 2/20 0.48
SLC22A6 Q4U2R8 1/20 0.48
SLC22A8 Q8TCC7 1/20 0.48
MEN1 O00255 1/20 0.48
ESR1 P03372 1/20 0.48
ALOX15 P16050 1/20 0.48
PDE4A P27815 1/20 0.48
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1636599 1.00 NOD1 (0.60) NOD1GPR84PPARGPPARDPPARA
SCHEMBL1636601 1.00 NOD1 (0.60) NOD1GPR84PPARGPPARDPPARA
SCHEMBL8383011 1.00 NOD1 (0.60) NOD1GPR84PPARGPPARDPPARA
SCHEMBL3249899 1.00 NOD1 (0.60) NOD1GPR84PPARGPPARDPPARA
SCHEMBL4826954 1.00 NOD1 (0.60) NOD1GPR84PPARGPPARDPPARA
SCHEMBL25244619 1.00 NOD1 (0.60) NOD1GPR84PPARGPPARDPPARA
SCHEMBL2721132 1.00 NOD1 (0.60) NOD1GPR84PPARGPPARDPPARA
SCHEMBL2721131 1.00 NOD1 (0.60) NOD1GPR84PPARGPPARDPPARA
SCHEMBL8383009 1.00 NOD1 (0.60) NOD1GPR84PPARGPPARDPPARA
SCHEMBL4826965 1.00 NOD1 (0.60) NOD1GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020182227-A1 PREPARATION METHOD FOR HIGH PURITY LIRAGLUTIDE SIDE CHAIN 美药星(南京)制药有限公司 2020-09-17 WO claimed
CN-108888523-A A kind of sea salt is feeding to treat clean powder 岳东 2018-11-27 CN claimed
CN-108653062-A A kind of plant polypeptide shampoo 岳东 2018-10-16 CN claimed
CN-104383958-B Heterogeneous ultraviolet-Fenton oxidation catalyst and preparation and application thereof 上海交通大学 2017-02-15 CN claimed
CN-119486725-A (2E) Mixtures and uses of (E) -3- (1, 3-benzodioxol-5-yl) -N-phenyl-N- (tetrahydro-3-furanyl) -2-propenamide 西姆莱斯有限公司 2025-02-18 CN disclosed
CN-115135307-B Cell delivery vehicle 株式会社ITO 2024-11-22 CN disclosed
CN-118922168-A Sun cream additive 西姆莱斯股份公司 2024-11-08 CN disclosed
CN-118891030-A Hair care compositions 西姆莱斯股份公司 2024-11-01 CN disclosed
CN-111381017-B Five-classification hemolytic agent for white blood cells, preparation method, blood analyzer and detection method 深圳市帝迈生物技术有限公司 2023-04-18 CN disclosed
CN-109984953-B Protein peptide gel for bath and skin cleaning and preparation method thereof 宁波御坊堂生物科技有限公司 2022-08-19 CN disclosed
CN-114728092-A Edge block with improved odor performance 西姆莱斯股份公司 2022-07-08 CN disclosed
CN-114728254-A Polyurea microcapsules and liquid surfactant system containing the same 西姆莱斯股份公司 2022-07-08 CN disclosed
US-20170209522-A1 Composition for External Application ROHTO PHARMACEUTICAL CO., LTD. (JP) 2017-07-27 US disclosed
CN-104383958-B Heterogeneous ultraviolet-Fenton oxidation catalyst and preparation and application thereof 上海交通大学 2017-02-15 CN disclosed
CN-100464730-C Composition of skin cleanser KAO CORP (JP) 2009-03-04 CN disclosed
US-7416891-B2 Reagent and method for classifying leucocytes SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD (CN) 2008-08-26 US disclosed
US-20070269896-A1 Reagent and method for classifying leucocytes SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 2007-11-22 US disclosed
CN-1230513-C Detergent compositions UNILEVER NV (NL) 2005-12-07 CN disclosed
CN-1478462-A Composition of skin cleanser 花王株式会社 2004-03-03 CN disclosed
US-5183601-A Mixture of polyoxazoline and surfactant KAO CORPORATION (JP) 1993-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170209522-A1 Composition for External Application COL1A1, COL14A1, COL2A1 NOD1 4192/4885GPR84 263/4885PPARG 279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.